Nifty Pharma index is down over 20% from its 52-week high of 13,753.50, which indicates a bearish phase for the index. Glenmark, Cipla are ...

Indian drug makers were more affected by the drop in volumes in FDCs than multinational drug makers in the country, according to PharmaTrac...